Eli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use ...

Scientists are testing a one-time gene-editing treatment that could lower dangerous cholesterol for years -- potentially ...

The diabetes drug, already the top-prescribed branded type 2 diabetes medicine in the U.S., showed an 8% lower rate of major ...

"This young lady did nothing wrong in her life," Clancy's defense said. "She was a nurse, a daughter, a wife and a darn good ...

A small gene-editing study significantly reduced LDL cholesterol levels, and the results have stuck a year later.

Aug 28(Reuters) - The U.S. FDA on Friday approved the use of Eli Lilly's Mounjaro to reduce the chances of heart attack or ...

The FDA just approved this year’s Covid vaccines - here’s what you need to know about the shots - The vaccines are expected ...

The Camino de Sonoma — an epic, six-stage pilgrimage from Sonoma to Fort Ross — becomes a transformational odyssey for ...

Arkansas awarded $149.3 million in federal funding to 50 projects to support rural healthcare efforts statewide, Gov. Sarah ...

Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news ...

With the approval, Eli Lilly’s Mounjaro becomes the first dual GIP/GLP-1 receptor agonist indicated to lower the risk of ...

While both of these breakfast options offer some heart-protective benefits, you may consider reaching for cottage cheese if ...